OMB APPROVAL
------------------------------
OMB Number 3235-0145
Expires: December 31, 1997
Estimated average burden
hours per response.......14.90
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 7 )*
Merit Medical Systems, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, No Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
589889-10-4
----------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 5 Pages
<PAGE>
CUSIP No. 589889-10-4 Page 2 of 5 Pages
13G
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. or I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Fred P. Lampropoulos
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
574,898
NUMBER OF ------------------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED BY None
EACH ------------------------------------------------------------
REPORTING 7 SOLE DISPOSITIVE POWER
PERSON
WITH 574,898
------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
None
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
574,898
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.8%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 589889-10-4 Page 3 of 5 Pages
13G
Item 1.
(a) Name of Issuer: Merit Medical Systems, Inc.
(b) Address of Issuer's Principal Executive Offices: 1600 West Merit
Parkway, South Jordan, Utah 84095
Item 2.
(a) Name of Person Filing: Fred P. Lampropoulos (the "Reporting Person")
(b) Address of Principal Business Office or, if none, Residence: 1600
West Merit Parkway, South Jordan, Utah 84095
(c) Citizenship: United States
(d) Title of Class of Securities: Common Stock, no par value (the
"Common Stock")
(e) CUSIP Number: 589889-10-4
Item 3.
This statement is not filed pursuant to Rule 13d-1(b) or 13d-2(b).
Item 4. Ownership
(a) Amount Beneficially Owned: As of December 31, 1997 the Reporting
Person was the owner of 574,898 shares of the Common Stock, which
included 10,821 shares owned by the Reporting Person pursuant to the
Issuer's 401(k) Plan, based upon the most recent plan statement
timely distributed, and 36,500 shares that the Reporting Person had
the right to acquire pursuant to currently exercisable options.
(b) Percent of Class: 7.8%
(c) Number of shares as to which the Reporting Person has:
(i) sole power to vote or to direct the vote: 574,898
(ii) shared power to vote or to direct the vote: None
(iii) sole power to dispose or to direct the disposition of: 574,898
(iv) shared power to dispose or to direct the disposition of: None
<PAGE>
CUSIP No. 589889-10-4 Page 4 of 5 Pages
13G
Item 5. Ownership of Five Percent or Less of a Class
This statement is not being filed to report the fact that as of the
date hereof the Reporting Person has ceased to be the beneficial owner of
more than five percent of the class of securities.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
Not applicable.
<PAGE>
CUSIP No. 589889-10-4 Page 5 of 5 Pages
13G
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
DATED: February 13, 1998
FRED P. LAMPROPOULOS
By /s/ KENT W. STANGER
-----------------------------------
Kent W. Stanger, Attorney-in-Fact,
pursuant to a Power of Attorney
dated February 8, 1996, a manually
signed copy of which is filed
herewith and incorporated herein by
this reference
MERIT MEDICAL SYSTEMS, INC.
POWER OF ATTORNEY
For Executing Schedule 13G and Schedule 13D
Know all by these presents, that the undersigned hereby constitutes and
appoints Kent W. Stanger his true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned Schedules 13G and 13D
(including any amendments thereto) which may be required to be filed
in accordance with Sections 13(d) and 13(g) of the Securities
Exchange Act of 1934 and the rules thereunder as a result of the
undersigned's ownership of or transactions in securities of Merit
Medical Systems, Inc.;
(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete the execution of any
such Schedule 13G or 13D and the timely filing of such form with the
United States Securities and Exchange Commission and any other
authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in his discretion.
The undersigned hereby grants to such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary and proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or his
substitute or substitutes, shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorney-in-fact, in serving in such capacity at
the request of the undersigned, is not assuming any of the undersigned's
responsibilities to comply with Section 13 of the Securities Exchange Act of
1934.
Photographic copies of this Power of Attorney shall have the same force
and effect as the original.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 8th day of February, 1996.
/s/ FRED P. LAMPROPOULOS
---------------------------------
Signature
Fred P. Lampropoulos
---------------------------------
Print Name
